Beijing To Set Up International Pharmaceutical Technology Transfer Platform
This article was originally published in PharmAsia News
Executive Summary
Beijing Equity Exchange, Capital Science & Technology Group and China Center for Pharmaceutical International Exchange recently signed an agreement to jointly establish a platform providing special services for pharmaceutical corporations, R&D institutions and investment organizations. The platform aims to forge a complete pharmaceutical technology transfer service chain for consultation, assessment, investment, acquisition and reorganization. Its competitive advantages include: comprehensive equity exchange system and facilities; worldwide information distribution network; abundant investment resources; international collaboration channels; and capability to integrate medical research institutions. (Click here for more - Chinese Language)
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.